RECoVER (Rapid European SARS-CoV-2 Emergency Research response)

RECoVER is a comprehensive research response that addresses the urgent questions for clinical and public health interventions in light of the SARS-CoV-2 outbreak. It does so using a multidisciplinary approach combining clinical studies in primary care and hospitals, epidemiological studies and modelling as well as clinical biological studies, and social sciences.

RECoVER includes the funding of REMAP-COVID, an international Adaptive Platform Trial for COVID-19 therapeutics, which is an extension of the pre-existing REMAP-CAP platform trial for patients hospitalised with community-acquired pneumonia. ECRIN will lead the coordination module between this and the other large COVID-19 European Adaptive Platform trial (EU-RESPONSE) in order to maximize synergies, avoid redundancies, and enable a more efficient search for treatments.

RECoVER is funded by the European Commission under grant agreement number 101003589.

Project news